Abstract: The invention relates to compounds and composition for the treatment and prevention of cancer. The invention also covers all diseases that may be treated by selective modulation of levels of reactive oxygen species in diseased cells versus normal cells. Methods for the preparation and administration of such compositions are also disclosed.
Type:
Application
Filed:
November 16, 2012
Publication date:
August 8, 2013
Applicants:
THE GENERAL HOSPITAL CORPORATION, CANTHERA THERAPEUTICS INC.
Inventors:
Canthera Therapeutics Inc., The General Hospital Corporation
Abstract: The invention relates to compounds and composition for the treatment and prevention of cancer. The invention also covers all diseases that may be treated by selective modulation of levels of reactive oxygen species in diseased cells versus normal cells. Methods for the preparation and administration of such compositions are also disclosed.
Type:
Grant
Filed:
September 2, 2010
Date of Patent:
January 8, 2013
Assignees:
Canthera Therapeutics, The Massachusetts General Hospital Corporation
Inventors:
Michael Andrew Foley, Robert Gould, Peter Elliott, Anna Mandinova
Abstract: The invention relates to compounds and composition for the treatment and prevention of cancer. The invention also covers all diseases that may be treated by selective modulation of levels of reactive oxygen species in diseased cells versus normal cells. Methods for the preparation and administration of such compositions are also disclosed.
Type:
Grant
Filed:
February 16, 2011
Date of Patent:
November 27, 2012
Assignees:
Canthera Therapeutics Inc., The General Hospital Corporation
Inventors:
Michael Andrew Foley, Robert Gould, Peter Elliott, Anna Mandinova, Sam Lee
Abstract: The invention relates to compounds and composition for the treatment and prevention of cancer. The invention also covers all diseases that may be treated by selective modulation of levels of reactive oxygen species in diseased cells versus normal cells. Methods for the preparation and administration of such compositions are also disclosed.
Type:
Application
Filed:
June 17, 2011
Publication date:
June 21, 2012
Applicant:
CANTHERA THERAPEUTICS, INC.
Inventors:
Michael Andrew Foley, Robert Gould, Peter Elliott, Anna Mandinova, Sam Lee
Abstract: The invention relates to compounds and composition for the treatment and prevention of cancer. The invention also covers all diseases that may be treated by selective modulation of levels of reactive oxygen species in diseased cells versus normal cells. Methods for the preparation and administration of such compositions are also disclosed.
Type:
Application
Filed:
February 16, 2011
Publication date:
March 8, 2012
Applicant:
CANTHERA THERAPEUTICS, INC.
Inventors:
PETER ELLIOTT, ANNA MANDINOVA, MICHAEL ANDREW FOLEY, ROBERT GOULD, SAM LEE
Abstract: The invention relates to compounds and composition for the treatment and prevention of cancer. The invention also covers all diseases that may be treated by selective modulation of levels of reactive oxygen species in diseased cells versus normal cells. Methods for the preparation and administration of such compositions are also disclosed.
Type:
Application
Filed:
September 2, 2010
Publication date:
March 3, 2011
Applicant:
CANTHERA THERAPEUTICS, INC.
Inventors:
Michael Andrew Foley, Robert Gould, Peter Elliott, Anna Mandinova, Sam Lee